Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06934447
What this trial is testing

Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

Who this might be right for
CAR T Cell TherapySystemic Lupus ErythematosusBCMA
The Children's Hospital of Zhejiang University School of Medicine 18
Testing effectiveness (Phase 2)Looking for participantsNCT06434363
What this trial is testing

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Who this might be right for
Autoimmune DisordersSystemic SclerosisSystemic Lupus Erythematosus+2 more
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT00119678
What this trial is testing

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 183
Early research (Phase 1)Looking for participantsNCT06249438
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Systemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)+3 more
RenJi Hospital 30
Testing effectiveness (Phase 2)UnknownNCT05929248
What this trial is testing

Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia

Who this might be right for
Systemic Lupus Erythematosus
Guanmin Gao 64
Early research (Phase 1)Looking for participantsNCT06308978
What this trial is testing

FT819 in B-cell Mediated Autoimmune Disease

Who this might be right for
Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Systemic Sclerosis (SSc)+2 more
Fate Therapeutics 244
Not applicableStudy completedNCT02530944
What this trial is testing

Web-based Genetic Research on Lupus

Who this might be right for
Systemic Lupus Erythematosus
23andMe, Inc. 5,000
Not applicableStudy completedNCT06720584
What this trial is testing

Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Duke University 36
Very early researchLooking for participantsNCT07193810
What this trial is testing

CC312 for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
SLE - Systemic Lupus ErythematosusIIM- Idiopathic Inflammatory MyopathiesSSc-Systemic Sclerosis
CytoCares Inc 6
Not applicableStudy completedNCT05260255
What this trial is testing

Effect of Vitamin D Supplement on Disease Activity in SLE

Who this might be right for
Vitamin D DeficiencyHypocalcemiaHyperparathyroidism+1 more
Department of Medical Services Ministry of Public Health of Thailand 100
Testing effectiveness (Phase 2)Study completedNCT01170585
What this trial is testing

A Trial of Rosuvastatin in Systemic Lupus Erythematosus

Who this might be right for
AtherosclerosisSystemic Lupus Erythematosus
Imperial College London 33
Early research (Phase 1)UnknownNCT06421701
What this trial is testing

Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Second Affiliated Hospital, Zhejiang University, School of Medicine 10
Not applicableUnknownNCT01712529
What this trial is testing

Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Federal University of São Paulo 38
Not applicableNot Yet RecruitingNCT07350772
What this trial is testing

It is an Observational Study That Compare Prognosis of Typical and Atypical Systemic Lupus Erythematosus Presentation

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Sohag University 400
Early research (Phase 1)Not Yet RecruitingNCT06468683
What this trial is testing

F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosis
Shanghai Simnova Biotechnology Co.,Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT01135459
What this trial is testing

Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Cephalon, Inc. 183
Post-approval studies (Phase 4)Looking for participantsNCT07760480
What this trial is testing

Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus (SLE)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 55
Early research (Phase 1)UnknownNCT00985803
What this trial is testing

Physical Activity in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Federal University of São Paulo 60
Testing effectiveness (Phase 2)Looking for participantsNCT06182969
What this trial is testing

APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.

Who this might be right for
SLE
Ascentage Pharma Group Inc. 40
Post-approval studies (Phase 4)Study completedNCT01769937
What this trial is testing

Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus Systemic Exacerbation
Fiechtner, Justus J., M.D., P.C. 10
Next Page